Loading…
Multiple law firms have filed suits on June 06, 2025.
UroGen Pharma Ltd. (URGN) is facing class action lawsuits filed by The Law Offices of Frank R. Cruz, Faruqi & Faruqi, LLP, and Rosen Law Firm. The suits allege that the company made materially false and misleading statements and/or failed to disclose material adverse facts about its business, operations, and prospects.
The complaints do not specify monetary amounts or other details beyond the allegations. UroGen Pharma has a free float of 37,059,100 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.